| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $8.6M | — | -38.7% |
| Cost of Revenue | $5.4M | — | -38.5% |
| R&D Expense | $14.6M | — | +15.0% |
| SG&A Expense | $11.3M | — | -4.2% |
| Operating Income | -$27.8M | — | -9.7% |
| Pre-tax Income | -$33.7M | — | -104.8% |
| Income Tax | $67K | — | -18.3% |
| Net Income | -$33.8M | — | -100.8% |
| EPS (Basic) | -$0.15 | — | -66.7% |
| EPS (Diluted) | -$0.15 | — | -66.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $221.0M | -6.7% | +194.2% |
| Accounts Receivable | $3.7M | +2.9% | -70.0% |
| Inventory | $14.9M | +12.4% | -7.1% |
| Current Assets | $246.2M | -5.3% | +127.4% |
| Total Assets | $481.4M | -3.8% | +29.8% |
| Current Liabilities | $56.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$16.4M | — | -20.9% |
| Capital Expenditures | $388K | — | +846.3% |
| Investing Cash Flow | -$388K | — | -846.3% |
| Financing Cash Flow | $1.5M | — | +60.0% |
| Free Cash Flow | -$16.8M | — | -23.4% |
| +194.4% |
| Total Liabilities | $61.3M | +7.9% | +111.4% |
| Stockholders' Equity | $420.0M | -5.3% | +22.9% |